Patients with a higher plasma Gal-3 level (>17.8 ng/mL) also had a significantly higher increase in LAD within 6 months post-MI compared to those with a plasma Gal-3 level below this value (Supplementary Table S4). This evidence concerns the gene LGALS3 and myocardial infarction.